That's a wrap on #PCCS2026. Thank you to our speakers and everyone who joined us over two days of excellent discussion on cardiovascular prevention, heart failure, and treatment innovation. Recordings coming soon.
buff.ly/9bgZe7r

That's a wrap on #PCCS2026. Thank you to our speakers and everyone who joined us over two days of excellent discussion on cardiovascular prevention, heart failure, and treatment innovation. Recordings coming soon.
buff.ly/9bgZe7r
Closing #PCCS2026 with GLP-1s and lifestyle medicine.
The message for primary care: match treatment to the individual, support sustainable lifestyle change and think beyond weight alone to wider cardiometabolic health.
Live at #PCCS2026: the data captured every day in primary care can help power cardiovascular research.
From identifying eligible patients to generating evidence, routine data can connect everyday care with tomorrow’s treatments.
Live at #PCCS2026: medicines adherence isn’t simply an information problem.
Ask what gets in the way, understand the individual barriers and tailor the approach.
Sometimes changing the conversation matters as much as the prescription.
Day 2 at #PCCS2026 starts with heart failure: think HF earlier, use NT-proBNP to support diagnosis, code the phenotype accurately and optimise treatment promptly.
For HFrEF, think four pillars and early action.
Day 2 of #PCCS2026 starts now.
Heart failure, medicines adherence and GLP1s on the agenda. Join us live.
pccsuk.org/events/1016/...
Day 1 of #PCCS2026 done. Thanks to everyone who joined for sessions on CVD prevention, hypertension, and CKD and PAD care. Back tomorrow at 08:45 for Day 2. buff.ly/9bgZe7r
Closing Day 1 at #PCCS2026 with one clear message: heart, kidney & vascular risk can’t be managed in silos. Check eGFR + uACR, recognise PAD and use every diagnosis to address wider cardiovascular risk.
Connect the dots.
Live at #PCCS2026: CVD remains under-recognised and under-treated in women. Pregnancy complications, gestational diabetes and early menopause are important cardiovascular risk markers.
Prevention starts by asking the right questions.
Live at #PCCS2026: innovation in CVD care isn't about more clinics, it's about smarter prevention.
Use data to find risk earlier, empower MDTs, support home monitoring and move from reactive care to proactive prevention.
Live at #PCCS2026: the future of hypertension care is based on earlier identification, team-based care, home BP monitoring and faster optimisation can improve outcomes while making services more sustainable.
COPD and CVD can't be treated separately.
At #PCCS2026, @bevbostock.bsky.social highlighted that every COPD review should also be a cardiovascular review.
Prevention means optimising risk factors, vaccination and patient self-management.
Live at #PCCS2026: four nations, one clear message. Find CVD risk earlier, treat to target and focus support where need is greatest.
For primary care, prevention must become systematic, proactive and equitable.
The #PCCS2026 Annual Conference "New Frontiers in Cardiovascular Care" kicks off today, free and fully virtual.
Two days of expert sessions on primary care cardiovascular practice. Join us. buff.ly/9bgZe7r
🚨 One day to go until our Annual Conference. Two days of expert sessions on primary care cardiovascular practice, free and fully virtual. Not registered yet? There's still time. #PCCS2026